OA15.05LB Cross-reactivity between HIV-1 bnAbs and parasite glycansOral Abstract SessionNovel vaccine and other prevention approaches
PE07.08 COVID-19: a major challenge to sex work in Nairobi, KenyaE-posterCOVID research: Applying lessons from HIV prevention to SARS CoV-2
PE07.07 COVID-19 vaccine attitudes among healthcare workers in New York City: Preliminary findings from the Antibody Response Monitoring for Occupational Resilience (ARMOR) studyE-posterCOVID research: Applying lessons from HIV prevention to SARS CoV-2
PE06.06 Covid-19 non-pharmacological public health response: Adapting virtual support to optimize peer (Thetha Nami) delivery of HIV prevention and care to adolescents and young adults in rural KwaZulu-NatalE-posterContraception, pregnancy and HIV prevention (incl. PMTCT)
PE07.01 COVID-19 and associated disruptions may indirectly affect HIV outcomes in two capital cities in Western/Central Africa: a modelling studyE-posterCOVID research: Applying lessons from HIV prevention to SARS CoV-2
PE01.19 Counselors’ acceptability of adherence counseling session recording, fidelity monitoring, and feedback in a multi-site HIV prevention study in four African countriesE-posterBehavioural and social science research
PE19.04 Correlates of STI acquisition during the first years after sexual initiation: a longitudinal cohort study of sexually inexperienced adolescent girls and young women in KenyaE-posterMicrobiome & STI: impact on prevention
OA02.02 Correlates of high HIV transmission areas in a generalized hyperendemic setting: findings from a national survey in EswatiniOral Abstract SessionTreatment as prevention
PE04.01 Correlates of dapivirine vaginal ring uptake among women participating in an open label extension trial-MTN-025/HOPEE-posterClinical trial results
PU25.02 Correlates of adherence to the dapivirine vaginal ring for HIV-1 preventionPublication OnlyProduct acceptability and adherence
seek-warrow-warrow-eseek-e341 - 350 of 444 items